Effect of magnesium supplements on serum C-reactive protein: a systematic review and meta-analysis

Archives of Medical Science : AMS
May 2018
Citations:64
Influential Citations:1
Systematic Reviews / Meta-Analyses
81
S2 IconPDF Icon

Enhanced Details

Methods
Eight randomized controlled trials; 349 participants; adults aged 18–85; mixed genders (one study female-only); parallel or crossover designs.
Intervention
Oral magnesium supplementation; daily dose 320–1500 mg; duration from 8 h to 6.5 months.
Results
Magnesium supplementation significantly reduced serum C-reactive protein (CRP) by -1.33 mg/L (95% CI -2.63 to -0.02). IL-6 and fasting blood glucose showed no significant changes. Results were robust to sensitivity analyses; CRP change did not depend on dose or duration. Subgroup with baseline CRP ≥ 2 mg/dL showed greater reductions (-2.95 mg/dL, p<0.001). Publication bias was not confirmed. Authors conclude that magnesium may lower CRP levels, but larger, longer trials are needed to confirm and clarify mechanisms.
Limitations
Small sample sizes in most trials; heterogeneity across populations and baseline CRP; varying magnesium doses and durations; some studies had risk of bias in allocation or blinding; potential publication bias; limited number of studies and short follow-up.

Abstract

Introduction The aim of the study was to undertake a systematic review and meta-analysis of prospective studies to determine the effect of magnesium (Mg) supplementation on C-reactive protein (CRP). Design: Systematic review and meta-analysis of rand...